Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 31

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 31
---
.  Significant segment expenses are the expense category details regularly provided to the CODM to allocate resources to the segments and to evaluate segment performance.  Detailed segment data for the years ended December 31 is as follows ($ in millions):BiotechnologyLife SciencesDiagnosticsOther (a)Total CompanyYear Ended December 31, 2024Sales (GAAP)$6,759 $7,329 $9,787 $— $23,875 Less:Depreciation(151)(167)(394)(9)(721)Amortization of intangible assets(863)(576)(192)— (1,631)Impairments(b)— (222)(43)— (265)Other segment expenses(c)(4,060)(5,485)(6,533)(317)(16,395)Operating profit$1,685 $879 $2,625 $(326)$4,863 Year Ended December 31, 2023Sales (GAAP)$7,172 $7,141 $9,577 $— $23,890 Less:Depreciation(162)(129)(379)(5)(675)Amortization of intangible assets(864)(429)(198)— (1,491)Impairments(b)(54)— (23)— (77)Other segment expenses(c)(4,183)(5,374)(6,571)(317)(16,445)Operating profit$1,909 $1,209 $2,406 $(322)$5,202 Year Ended December 31, 2022Sales (GAAP)$8,758 $7,036 $10,849 $— $26,643 Less:Depreciation(190)(112)(387)(9)(698)Amortization of intangible assets(812)(419)(203)— (1,434)Other segment expenses(c)(4,748)(5,091)(6,823)(313)(16,975)Operating profit$3,008 $1,414 $3,436 $(322)$7,536 (a) Other consists of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance.(b) For information on the impairments, refer to Note 10. (c) Other segment expenses for each reportable segment include cost of sales, selling general and administrative expenses, research and development (“R&D